Amgen - PDFSEARCH.IO - Document Search Engine

Amgen
Results: 561

#	Item
401	One Amgen Center Drive Thousand Oaks, CA[removed][removed]www.amgen.com November 2005 Add to Reading List Source URL: www.fda.gov Language: English Erythropoiesis-stimulating agents Growth factors Hematopathology Amgen Erythropoietin Epoetin alfa Anemia Pure red cell aplasia Immunogenicity Medicine Biology Hematology
402	PDF Document Add to Reading List Source URL: www.fda.gov Language: English Immunosuppressants Clinical research Amgen Etanercept Rheumatoid arthritis Tumor necrosis factor-alpha Biologic Disease-modifying antirheumatic drug Placebo Medicine Health Pharmacology
403	FOOD AND DRUG ADMINISTRATION Add to Reading List Source URL: www.fda.gov Language: English Monoclonal antibodies Pyridines Eisai Eribulin Pralatrexate Denosumab Pfizer Amgen Food and Drug Administration Pharmacology Chemistry Pharmaceutical sciences
404	Wilcox Pharmacy/Option Care Respiratory Syncytial Virus (RSV) Prophylaxis Add to Reading List Source URL: dvha.vermont.gov Language: English - Date: 2013-05-21 21:10:49 Medical equipment Arthritis Immunosuppressants Amgen Etanercept SureClick Medical prescription Rheumatoid arthritis Autoinjector Medicine Health Pharmacology
405	Microsoft PowerPoint - Santana FDA[removed]ppt Add to Reading List Source URL: www.fda.gov Language: English - Date: 2008-12-16 15:53:26 Cytokines Growth factors Hematology Amgen Transplantation medicine Granulocyte colony-stimulating factor Hematopoietic stem cell transplantation Haematopoiesis Macrophage colony-stimulating factor Biology Medicine Anatomy
406	FDA Approved: [removed]PROCRIT® (Epoetin alfa) FOR INJECTION WARNINGS: INCREASED MORTALITY, SERIOUS CARDIOVASCULAR and THROMBOEMBOLIC Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2010-02-16 13:48:13 Hematology Growth factors Drugs in sport Amgen Erythropoietin Anemias Epoetin alfa Hematocrit Chronic kidney disease Medicine Erythropoiesis-stimulating agents Biology
407	Microsoft PowerPoint - ASCT0631 FDA presentation grupp.ppt Add to Reading List Source URL: www.fda.gov Language: English - Date: 2008-12-16 15:53:27 Transplantation medicine Amgen Growth factors Stem cells Hematopoietic stem cell transplantation Granulocyte colony-stimulating factor Graft-versus-host disease Apheresis Filgrastim Medicine Biology Hematology
408	FOOD AND DRUG ADMINISTRATION Center for Drug Evaluation and Research Joint Meeting of the Medical Imaging Drugs Advisory Committee (MIDAC) and the Oncologic Drugs Advisory Committee (ODAC) FDA White Oak Campus, Building Add to Reading List Source URL: www.fda.gov Language: English Pharmaceutical sciences Amgen Growth factors Therapeutics United States Public Health Service Filgrastim Center for Drug Evaluation and Research National Institute of Allergy and Infectious Diseases Pegfilgrastim Food and Drug Administration Pharmacology Medicine
409	FOOD AND DRUG ADMINISTRATION Center for Drug Evaluation and Research Joint Meeting of the Medical Imaging Drugs Advisory Committee (MIDAC) and the Oncologic Drugs Advisory Committee (ODAC) FDA White Oak Campus, Building Add to Reading List Source URL: www.fda.gov Language: English Pharmaceutical sciences Amgen Growth factors Therapeutics United States Public Health Service Filgrastim Center for Drug Evaluation and Research National Institute of Allergy and Infectious Diseases Pegfilgrastim Food and Drug Administration Pharmacology Medicine
410	NEUPOGEN® (filgrastim) DESCRIPTION Filgrastim is a human granulocyte colony-stimulating factor (G-CSF)‚ produced by recombinant DNA technology. NEUPOGEN® is the Amgen Inc. trademark for filgrastim‚ which has been s Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2013-09-17 10:57:16 Growth factors Hematology Filgrastim Oncology Cytokines Medicine Biology Amgen